Rinsho Shinkeigaku (Clinical Neurology)

Original Article

The questionnaire survey regarding the impact of COVID-19 pandemic on Parkinson's disease patients

Toshiki Tezuka, M.D.1j, Takashi Osada, M.D., Ph.D.2j, Yasuo Terayama, M.D., Ph.D.3j, Masahito Kubota, M.D.1j, Shohei Okusa, M.D.1j, Gen Shiihashi, M.D., Ph.D.3j, Shin-ichiro Kubo, M.D., Ph.D.3j4j, Norihiro Suzuki, M.D., Ph.D.3j, Jin Nakahara, M.D., Ph.D.1j and Morinobu Seki, M.D., Ph.D.1j

1) Department of Neurology, Keio University School of Medicine
2) Department of Neurosurgery (Stroke), Saitama Medical University International Medical Center
3) Department of Neurology, Shonan Keiiku Hospital
4) Department of Neurology, Eisei Hospital

We conducted the multicenter questionnaire survey targeting patients with Parkinson's disease (PD) in order to investigate the impacts on their daily lives and their requests to hospitals in the pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Mainly using open-ended questionnaire, we asked their anxiety, troubles they are facing, and requests toward hospitals in the pandemic of SARS-CoV-2. Two hundred fifth-eight PD patients answered the questionnaire. There were various opinions about anxiety such as gPD patients are susceptible and vulnerable to SARS-CoV-2h (36.8%). Concerning the troubles in the pandemic, the most frequent answer was that they couldn't participate in the rehabilitation and elderly day care (38.4%). Relatively many PD patients requested telemedicine (29.5%), whereas some people hoped face-to-face medical care (8.1%). There were demands about the delivery of medications (50.0%), the establishment of telephone consultations (43.8%), resources for rehabilitation at home (43.8%). The medical care adapted to the anxiety, trouble and requests of PD patients will be required in the era when we have to live with SARS-CoV-2.
Full Text of this Article in Japanese PDF (1357K)

(CLINICA NEUROL, 62: 8|14, 2022)
key words: Parkinson's disease, severe acute respiratory syndrome coronavirus 2, multicenter questionnaire survey, anxiety, quality of life

(Received: 4-Jul-21)